DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Prednimustine

Prednimustine

  • Isolation and Characterization of a Chinese Hamster Ovary Cell Line Resistant to Bifunctional Nitrogen Mustards1

    Isolation and Characterization of a Chinese Hamster Ovary Cell Line Resistant to Bifunctional Nitrogen Mustards1

  • Section B Changed Classes/Guidelines Final

    Section B Changed Classes/Guidelines Final

  • Acalabrutinib and Vistusertib Protocol: ACE-LY-110

    Acalabrutinib and Vistusertib Protocol: ACE-LY-110

  • Haematological Toxicity: a Marker of Adjuvant Chemotherapy Efficacy in Stage 11 and III Breast Cancer

    Haematological Toxicity: a Marker of Adjuvant Chemotherapy Efficacy in Stage 11 and III Breast Cancer

  • WO 2012/136553 Al 11 October 2012 (11.10.2012) P O P C T

    WO 2012/136553 Al 11 October 2012 (11.10.2012) P O P C T

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

    NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

  • Prognosticfactors in Patientswith Advancedstage Prostatecancer1

    Prognosticfactors in Patientswith Advancedstage Prostatecancer1

  • (12) United States Patent �(1O) Patent No.: �US 8,173,115 B2 Decuzzi Et Al

    (12) United States Patent (1O) Patent No.: US 8,173,115 B2 Decuzzi Et Al

  • Breast Cancer Secondary Acute Leukemia Following Mitoxantrone-Based High-Dose Chemotherapy for Primary Breast Cancer Patients

    Breast Cancer Secondary Acute Leukemia Following Mitoxantrone-Based High-Dose Chemotherapy for Primary Breast Cancer Patients

  • In Vitro Cytotoxic Effect of Melphalan and Pilot Phase II Study in Hormone-Refractory Prostate Cancer

    In Vitro Cytotoxic Effect of Melphalan and Pilot Phase II Study in Hormone-Refractory Prostate Cancer

  • Council of Europe Committee of Ministers (Partial

    Council of Europe Committee of Ministers (Partial

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • United States Patent (19) 11 Patent Number: 5,858,410 Muller Et Al

    United States Patent (19) 11 Patent Number: 5,858,410 Muller Et Al

  • Poison Or Antibiotic? a Guide to

    Poison Or Antibiotic? a Guide to "Class" Entries

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • MANUAL for Medical Facilities

    MANUAL for Medical Facilities

  • (12) United States Patent (10) Patent No.: US 9,345,766 B2 Zhang Et Al

    (12) United States Patent (10) Patent No.: US 9,345,766 B2 Zhang Et Al

Top View
  • United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0037090 A1 Mckearn Et Al
  • Anatomical Classification Guidelines V2016
  • Prednimustine
  • Ep 2425840 A1
  • TAR/W/87 21 Juin 1993 DOUANIERS ET LE COMMERCE Distribution Limitée
  • Customs Tariff - Schedule Xxi - 1
  • Chemical Protocol Review
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • Patient Drug Locker Procedures
  • Arylquinoline and Analog Compounds and Use Thereof to Treat Cancer David S
  • Mesh Terms for 2002
  • Chemotherapy Drugs
  • Sample List of Drugs That Should Be Handled As Hazardous*
  • NIOSH Alert: Preventing Occupational Exposures to Antineoplastic
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances


© 2024 Docslib.org    Feedback